查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941359

肺部标记市场报告：按癌症类型、标记类型、最终用户和地区划分（2026-2034 年）

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年全球肺部标记市场规模达5.285亿美元。展望未来，IMARC集团预测，到2034年，市场规模将达到11.685亿美元，2026年至2034年的复合年增长率为8.8%。

通常，肺部标记主要分为四类：EGFR、EML4-ALK、KRAS 和 BRAF。这些标记用于肺部介入治疗、肺部手术和诊断。此外，它们还用于肿瘤的检测、诊断、预后和后续观察，并根据检测结果为患者制定治疗方案。肺部标记仅作为辅助工具，需与多种影像检查和切片检查相结合才能确诊癌症。因此，肺部标记广泛应用于包括医院、门诊手术中心和专科诊所在内的各种医疗机构的胸腔镜手术中。

肺部标记需求的不断增长，源于呼吸系统疾病（如胸腔积液、胸膜间皮瘤和胸膜斑块）发病率的上升，而这些疾病的发生又与全球日益严重的空气污染密切相关。此外，被动吸烟的高暴露率和肺癌家族病史进一步增加了肺癌患者的数量，进一步推动了对肺部标记的需求。同时，人口快速老化和快节奏的消费生活方式导致的高吸烟率，也加剧了多种呼吸系统疾病的风险。此外，各国政府不断增加医疗保健支出，用于肺癌等危及生命的疾病的早期诊断和治疗，也推动了肺部标记在全球范围内的应用。此外，对肺癌诊断和治疗领域研发投入的增加，也进一步推动了对肺部标记的需求。肺部标记在医院、手术中心和诊所的广泛应用，以及其多样化的治疗用途，也推动了相关产品的需求。

本报告解答的关键问题：

  • 目前全球肺部标记市场的发展趋势如何？未来几年预计发展如何？
  • 新冠疫情对全球肺部标记市场产生了哪些影响？
  • 你们的主要市场区域有哪些？
  • 按癌症类型分類的市场组成是什么？
  • 依标记类型分類的市场区隔如何？
  • 依最终用户分類的市场区隔如何？
  • 产业价值链包含哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球肺部标记市场的结构是怎么样的？主要参与者有哪些？
  • 您所在产业的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

第五章：全球肺部标记市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按癌症类型分類的市场区隔

  • 非小细胞肺癌（NSCLC）
  • 小细胞肺癌（SCLC）

第七章 按标记类型分類的市场区隔

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • 其他的

第八章 按最终用户分類的市场细分

  • 医院
  • 诊断检查室
  • 其他的

第九章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他的
  • 中东和非洲
    • 土耳其
    • 伊朗
    • 其他的

第十章 SWOT 分析

第十一章 价值链分析

第十二章 波特五力分析

第十三章 价格指标

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Agilent Technologies, Inc.
    • Beckman Coulter, Inc.
    • Fujirebio Europe NV
    • Hologic, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • BioSpace, Inc.
Product Code: SR112026A2063

The global lung marker market size reached USD 528.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,168.5 Million by 2034, exhibiting a growth rate (CAGR) of 8.8% during 2026-2034.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Labs
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Iran
    • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Lung Marker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact Of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Non-Small Cell Lung Cancer (NSCLC)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Cell Lung Cancer (SCLC)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Marker Type

  • 7.1 EGFR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 EML4-ALK
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 KRAS
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 BRAF
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Japan
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 India
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 South Korea
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Australia
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Argentina
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
    • 9.4.4 Colombia
      • 9.4.4.1 Market Trends
      • 9.4.4.2 Market Forecast
    • 9.4.5 Chile
      • 9.4.5.1 Market Trends
      • 9.4.5.2 Market Forecast
    • 9.4.6 Peru
      • 9.4.6.1 Market Trends
      • 9.4.6.2 Market Forecast
    • 9.4.7 Others
      • 9.4.7.1 Market Trends
      • 9.4.7.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Turkey
      • 9.5.1.1 Market Trends
      • 9.5.1.2 Market Forecast
    • 9.5.2 Iran
      • 9.5.2.1 Market Trends
      • 9.5.2.2 Market Forecast
    • 9.5.3 Others
      • 9.5.3.1 Market Trends
      • 9.5.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Thermo Fisher Scientific Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Agilent Technologies, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fujirebio Europe N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hologic, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 F. Hoffmann-La Roche Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Siemens Healthineers
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 BioSpace, Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 2: Global: Lung Marker Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2025
  • Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2025
  • Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Turkey: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Iran: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Latin America: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Brazil: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Mexico: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Argentina: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Colombia: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Chile: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Peru: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Others: Lung Marker Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Global: Lung Marker Industry: SWOT Analysis
  • Figure 91: Global: Lung Marker Industry: Value Chain Analysis
  • Figure 92: Global: Lung Marker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Lung Marker Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million USD), 2026-2034
  • Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million USD), 2026-2034
  • Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Lung Marker Market: Competitive Structure
  • Table 7: Global: Lung Marker Market: Key Players